GlassScriptPhysician profile
Sharon Lynn Hill
NPI 1861484479
$2,744.96
in general payments reported to CMS, 2019-2025
24 companies · $661 in 2025
The $661 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $531 · 2023: $393 · 2024: $1,031 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,085.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $645.64 | 2022-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $506.44 | 2023-2024 | Zoryve |
| Genzyme Corporation | $356.29 | 2021-2025 | |
| Abbvie INC. | $331.74 | 2021-2025 | |
| Leo Pharma INC. | $91.03 | 2024-2025 | Adbry |
| Pfizer INC. | $86.54 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $86.53 | 2025 | |
| Paratek Pharmaceuticals, INC. | $81.89 | 2024 | Nuzyra |
| Genentech USA, INC. | $66.01 | 2022 | |
| Incyte Corporation | $65.18 | 2022-2025 | Opzelura |
| Dermavant Sciences, INC. | $52.95 | 2022-2024 | Vtama |
| Mayne Pharma Commercial LLC | $50.98 | 2025 | |
| Sun Pharmaceutical Industries INC. | $43.27 | 2022-2025 | |
| Galderma Laboratories, L.P. | $37.82 | 2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $36.81 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $34.24 | 2024 | |
| Ucb, INC. | $31.27 | 2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $23.28 | 2024 | Sotyktu |
| Organon LLC | $22.97 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.03 | 2022 | |
| Verrica Pharmaceuticals INC. | $20.21 | 2024 | Ycanth |
| Epi Health, LLC | $17.86 | 2022 | |
| Biofrontera INC. | $17.03 | 2021 | |
| Lilly USA, LLC | $16.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.